Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Biochimica Et Biophysica Acta. General Subjects|December 26, 2022
Metabolic reprograming of cancer as a therapeutic targetTatsuhiko Furukawa, Sho Tabata, Kentaro Minami, et al.Cancer Letters|April 19, 2008
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenograftsAkio Ooyama, Toshinori Oka, Hong-ye Zhao, et al.Anticancer Research|April 9, 2013
Influence of gefitinib and erlotinib on apoptosis and c-MYC expression in H23 lung cancer cellsMitsuhiro Suenaga, Masatatsu Yamamoto, Sho Tabata, et al.International Journal of Molecular Sciences|December 23, 2022
Nucleolar Stress Response via Ribosomal Protein L11 Regulates Topoisomerase Inhibitor Sensitivity of P53-Intact CancersYuka Ishihara, Kiyoshiro Nakamura, Shunsuke Nakagawa, et al.International Journal of Cancer|April 29, 2006
2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9Yuichi Nakajima, Misako Haraguchi, Tatsuhiko Furukawa, et al.Journal of Biochemistry|July 25, 2006
A functional role of intracellular loops of human multidrug resistance protein 1Xiao-Qin Ren, Tatsuhiko Furukawa, Masatatsu Yamamoto, et al.Pharmacological Research|April 1, 2018
Thymidine phosphorylase in cancer aggressiveness and chemoresistanceTatsuhiko Furukawa, Sho Tabata, Masatatsu Yamamoto, et al.Ecotoxicology (London, England)|August 22, 2014
Establishment of a primary hepatocyte culture from the small Indian mongoose (Herpestes auropunctatus) and distribution of mercury in liver tissueSawako Horai, Kumiko Yanagi, Tadashi Kaname, et al.Oncotarget|October 29, 2014
Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cellsSho Tabata, Ryuji Ikeda, Masatatsu Yamamoto, et al.Oncotarget|March 19, 2016
ATP7B expression confers multidrug resistance through drug sequestrationF M Moinuddin, Yoshinari Shinsato, Masaharu Komatsu, et al.Pageof 5